Home ETF List About

Portfolio Holdings Detail for ISIN IE00BL977C92
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares MSCI China UCITS ETF
IssuerBlackrock
ETF TickerICHD.AS(USD) CXE
ETF TickerICHD(USD) Euronext Amsterdam

Holdings detail for LEGN

Stock NameLegend Biotech Corp
TickerLEGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS52490G1022
LEI254900EIUFZTW136H859

Show aggregate LEGN holdings

News associated with LEGN

Brokerages Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $74.22
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month price […] - 2025-09-19 02:43:01
Legend Biotech Becomes Oversold (LEGN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-09-10 14:53:11
JPMorgan Chase & Co. Increases Legend Biotech (NASDAQ:LEGN) Price Target to $78.00
Legend Biotech (NASDAQ:LEGN – Get Free Report) had its price target raised by research analysts at JPMorgan Chase & Co. from $77.00 to $78.00 in a note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of […] - 2025-08-27 02:30:45
Legend Biotech Breaks Below 200-Day Moving Average - Notable for LEGN
In trading on Monday, shares of Legend Biotech Corp (Symbol: LEGN) crossed below their 200 day moving average of $36.28, changing hands as low as $35.23 per share. Legend Biotech Corp shares are currently trading off about 2.5% on the day. The chart below shows the one year pe - 2025-08-11 12:46:01
Legend Biotech (NASDAQ:LEGN) Rating Increased to Strong-Buy at Cantor Fitzgerald
Legend Biotech (NASDAQ:LEGN – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports. Other equities research analysts also recently issued research reports about the company. Johnson Rice reissued a “buy” rating on shares of Legend Biotech in a research report on […] - 2025-08-06 03:12:50
GAMMA Investing LLC Boosts Position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)
GAMMA Investing LLC increased its holdings in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 145.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,291 shares of the company’s stock after purchasing an additional 765 […] - 2025-07-11 04:12:51
Legend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC Wainwright
Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They currently have a $75.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 90.07% from the company’s previous close. A number of other […] - 2025-07-10 04:01:26
Rhumbline Advisers Purchases 391 Shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN)
Rhumbline Advisers lifted its position in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,029 shares of the company’s stock after acquiring an additional 391 shares during the quarter. Rhumbline Advisers’ holdings […] - 2025-06-20 04:25:11
Thursday's ETF with Unusual Volume: FTQI
The First Trust Nasdaq BuyWrite Income ETF is seeing unusually high volume in afternoon trading Thursday, with over 909,000 shares traded versus three month average volume of about 226,000. Shares of FTQI were down about 0.2% on the day. Components of that ETF with the highest - 2025-06-12 15:09:39
Tuesday's ETF with Unusual Volume: EEMA
The iShares MSCI Emerging Markets Asia ETF is seeing unusually high volume in afternoon trading Tuesday, with over 2.5 million shares traded versus three month average volume of about 92,000. Shares of EEMA were up about 0.3% on the day. Components of that ETF with the highest - 2025-06-10 14:57:32
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 36,181 Shares of Legend Biotech Co. (NASDAQ:LEGN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 36.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,438 shares of the company’s stock after […] - 2025-06-04 05:02:51
Nuveen Asset Management LLC Acquires 5,700 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Nuveen Asset Management LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 5.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 110,586 shares of the company’s stock after purchasing an additional 5,700 shares during the period. Nuveen Asset Management LLC’s […] - 2025-06-02 05:04:55
Legend Biotech Co. (NASDAQ:LEGN) Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC grew its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 127,900 shares of the company’s stock after acquiring an additional 39,197 shares during the quarter. Squarepoint Ops […] - 2025-05-27 05:13:00
Millennium Management LLC Has $8.31 Million Holdings in Legend Biotech Co. (NASDAQ:LEGN)
Millennium Management LLC lessened its stake in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 55.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 255,468 shares of the company’s stock after selling 314,908 shares during the quarter. Millennium Management LLC’s […] - 2025-05-26 04:42:54
Deutsche Bank AG Acquires 14,198 Shares of Legend Biotech Co. (NASDAQ:LEGN)
Deutsche Bank AG lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 135,067 shares of the company’s stock after acquiring an additional 14,198 shares during the period. Deutsche Bank […] - 2025-05-20 05:12:55
Legend Biotech (NASDAQ:LEGN) Hits New 12-Month Low After Analyst Downgrade
Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after Truist Financial lowered their price target on the stock from $88.00 to $71.00. Truist Financial currently has a buy rating on the stock. Legend Biotech traded as low as $27.54 and last traded at […] - 2025-05-16 03:02:47
Legend Biotech Co. (NASDAQ:LEGN) Stake Boosted by Stifel Financial Corp
Stifel Financial Corp increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 70.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,365 shares of the company’s stock after acquiring an additional 12,955 shares […] - 2025-05-09 05:58:54
Zurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)
Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company’s stock after selling 9,355 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Legend […] - 2025-03-19 05:40:51
Morgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock Price
Legend Biotech (NASDAQ:LEGN – Get Free Report) had its target price dropped by analysts at Morgan Stanley from $82.00 to $80.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 111.19% from the company’s current […] - 2025-03-19 04:28:56
Daiwa Securities Group Inc. Raises Stock Position in Legend Biotech Co. (NASDAQ:LEGN)
Daiwa Securities Group Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 165.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 8,516 shares of the company’s stock after acquiring an additional 5,309 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Legend Biotech were worth $278,000 as […] - 2025-03-17 06:06:55
Company News for Mar 12, 2025
Companies in The News Are: FRG, ORCL, LEGN, PAY - 2025-03-12 11:20:00
Legend Biotech Co. (NASDAQ:LEGN) Receives $79.50 Average PT from Brokerages
Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have been given a consensus rating of “Buy” by the twelve research firms that are covering the stock, MarketBeat Ratings reports. Twelve analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock […] - 2025-03-03 04:50:55
Legend Biotech Co. (NASDAQ:LEGN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in Legend Biotech Co. (NASDAQ:LEGN – Free Report) by 2.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 173,766 shares of the company’s stock after selling 3,461 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-02-14 07:35:09
Contrasting Legend Biotech (NASDAQ:LEGN) and COMPASS Pathways (NASDAQ:CMPS)
COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and Legend Biotech (NASDAQ:LEGN – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk. Earnings & Valuation This table compares COMPASS Pathways […] - 2025-02-06 04:06:58
How The Parts Add Up: KOMP Headed For $62
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-02-04 10:28:33

iShares MSCI China UCITS ETF LEGN holdings

DateNumber of LEGN Shares HeldBase Market Value of LEGN SharesLocal Market Value of LEGN SharesChange in LEGN Shares HeldChange in LEGN Base ValueCurrent Price per LEGN Share HeldPrevious Price per LEGN Share Held
2025-11-11 (Tuesday)118,977USD 3,810,833LEGN holding increased by 52350USD 3,810,8330USD 52,350 USD 32.03 USD 31.59
2025-11-10 (Monday)118,977USD 3,758,483LEGN holding decreased by -24986USD 3,758,4830USD -24,986 USD 31.59 USD 31.8
2025-11-07 (Friday)118,977LEGN holding increased by 382USD 3,783,469LEGN holding decreased by -55451USD 3,783,469382USD -55,451 USD 31.8 USD 32.37
2025-11-06 (Thursday)118,595USD 3,838,920LEGN holding increased by 42694USD 3,838,9200USD 42,694 USD 32.37 USD 32.01
2025-11-05 (Wednesday)118,595LEGN holding increased by 955USD 3,796,226LEGN holding increased by 25864USD 3,796,226955USD 25,864 USD 32.01 USD 32.05
2025-11-04 (Tuesday)117,640LEGN holding increased by 573USD 3,770,362LEGN holding increased by 8999USD 3,770,362573USD 8,999 USD 32.05 USD 32.13
2025-11-03 (Monday)117,067USD 3,761,363LEGN holding decreased by -31608USD 3,761,3630USD -31,608 USD 32.13 USD 32.4
2025-10-31 (Friday)117,067LEGN holding increased by 1146USD 3,792,971LEGN holding increased by 54519USD 3,792,9711,146USD 54,519 USD 32.4 USD 32.25
2025-10-30 (Thursday)115,921USD 3,738,452LEGN holding increased by 13910USD 3,738,4520USD 13,910 USD 32.25 USD 32.13
2025-10-29 (Wednesday)115,921USD 3,724,542LEGN holding decreased by -51005USD 3,724,5420USD -51,005 USD 32.13 USD 32.57
2025-10-28 (Tuesday)115,921LEGN holding increased by 579USD 3,775,547LEGN holding increased by 70762USD 3,775,547579USD 70,762 USD 32.57 USD 32.12
2025-10-27 (Monday)115,342USD 3,704,785LEGN holding increased by 29989USD 3,704,7850USD 29,989 USD 32.12 USD 31.86
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LEGN by Blackrock for IE00BL977C92

Show aggregate share trades of LEGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-07BUY382 31.800* 34.12
2025-11-05BUY95532.32531.610 31.682USD 30,256 34.15
2025-11-04BUY57332.80031.580 31.702USD 18,165 34.17
2025-10-31BUY1,14633.38931.810 31.968USD 36,635 34.20
2025-10-28BUY57932.57032.585 32.583USD 18,866 34.24
2025-10-23BUY96031.67032.450 32.372USD 31,077 34.30
2025-10-20BUY76832.91033.070 33.054USD 25,385 34.34
2025-10-17BUY2,49631.96032.270 32.239USD 80,469 34.36
2025-09-24BUY3,03032.88033.311 33.268USD 100,802 34.58
2025-08-20BUY51335.63036.700 36.593USD 18,772 34.56
2025-07-23BUY34644.32045.297 45.199USD 15,639 34.09
2025-07-17BUY52542.13042.670 42.616USD 22,373 33.71
2025-07-08BUY35037.49037.810 37.778USD 13,222 33.39
2025-07-07BUY1,40035.87036.005 35.992USD 50,388 33.36
2025-07-03BUY34835.64036.420 36.342USD 12,647 33.30
2025-06-25BUY88533.43033.980 33.925USD 30,024 33.18
2025-06-16BUY18235.84036.705 36.619USD 6,665 33.02
2025-06-06BUY1,22535.00035.195 35.175USD 43,090 32.69
2025-05-30SELL-12,19328.95029.070 29.058USD -354,304 32.95 Profit of 47,509 on sale
2025-05-28BUY4,04028.29028.850 28.794USD 116,328 33.11
2025-05-27BUY1,60828.76029.488 29.415USD 47,300 33.19
2025-05-23BUY20228.91029.400 29.351USD 5,929 33.36
2025-05-21BUY40228.33031.120 30.841USD 12,398 33.54
2025-05-16BUY60327.78028.480 28.410USD 17,131 33.83
2025-05-15SELL-40,60027.69028.830 28.716USD -1,165,870 33.97 Profit of 213,233 on sale
2025-05-12BUY99532.38033.300 33.208USD 33,042 34.22
2025-05-07BUY93231.47032.160 32.091USD 29,909 34.40
2025-05-06BUY2,37631.37033.390 33.188USD 78,855 34.48
2025-04-25BUY98034.28034.540 34.514USD 33,824 34.48
2025-04-15BUY78033.74035.110 34.973USD 27,279 34.78
2025-04-04BUY57632.01032.370 32.334USD 18,624 35.99
2025-03-28BUY76835.06035.740 35.672USD 27,396 36.67
2025-03-26BUY38434.67035.030 34.994USD 13,438 36.92
2025-03-20BUY19237.72038.000 37.972USD 7,291 37.10
2025-03-18BUY38637.88038.250 38.213USD 14,750 36.84
2025-03-17BUY2,89537.94038.500 38.444USD 111,295 36.66
2025-03-14BUY77237.20038.705 38.555USD 29,764 36.55
2025-03-12BUY37638.24038.700 38.654USD 14,534 35.49
2025-03-11BUY1,31637.19037.235 37.231USD 48,995 34.64
2025-03-10BUY2,99234.03035.400 35.263USD 105,507 35.26
2025-03-07BUY4,96635.26035.445 35.426USD 175,928 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LEGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19298,552313560,26753.3%
2025-09-18438,0300811,81054.0%
2025-09-17326,4210604,29654.0%
2025-09-16311,042401615,95250.5%
2025-09-15260,973622447,86258.3%
2025-09-12426,469700897,99047.5%
2025-09-11693,3380855,83381.0%
2025-09-10888,56401,313,42967.7%
2025-09-09340,4050706,28448.2%
2025-09-08217,4840481,96945.1%
2025-09-05494,7360832,55559.4%
2025-09-04184,0380343,13453.6%
2025-09-03269,7870497,65554.2%
2025-09-02107,7840208,50451.7%
2025-08-29352,5600434,68981.1%
2025-08-28150,9760247,24261.1%
2025-08-27238,4940431,59055.3%
2025-08-26254,6150364,72169.8%
2025-08-25211,6500359,26858.9%
2025-08-22179,1960268,63366.7%
2025-08-21247,4500388,07463.8%
2025-08-20309,4830452,61868.4%
2025-08-19205,4210287,26971.5%
2025-08-18216,6710285,12276.0%
2025-08-15291,5850472,78561.7%
2025-08-14364,8890500,56372.9%
2025-08-13393,9471,421557,98070.6%
2025-08-12294,4730535,56955.0%
2025-08-11211,1022,089693,89730.4%
2025-08-08161,6950501,44932.2%
2025-08-07178,4980390,08745.8%
2025-08-06120,604783441,00827.3%
2025-08-05109,8670234,84846.8%
2025-08-04128,5621,313300,07242.8%
2025-08-01161,9420534,93130.3%
2025-07-31300,3491,679523,29957.4%
2025-07-30248,9910668,47337.2%
2025-07-29148,8460593,88525.1%
2025-07-28169,80413460,46436.9%
2025-07-25141,564462607,48623.3%
2025-07-24226,07390389,60958.0%
2025-07-23387,09778614,67863.0%
2025-07-22276,984209600,77246.1%
2025-07-21247,0450370,66166.6%
2025-07-18453,846474647,20770.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.